4th International AIDS Society Conference on HIV Pathogenesis and Treatment


Sydney, Australia - July 22 - 25, 2007

AMATA STUDY: EFFECTIVENESS OF ANTIRETROVIRAL THERAPY IN BREASTFEEDING MOTHERS TO PREVENT POST-NATAL VERTICAL TRANSMISSION IN RWANDA

IAS Conf HIV Pathog Treat 2007 Jul 22-25;4th: Abstract No. TUAX102

Arendt V.1, Ndimubanzi P.2, Vyankandondera J.3, Ndayisaba G.2, Muganda j.4, Courteille O.2, Rutanga C.2, Havuga E.2, Dhont N.2, Mujawamassiga A.2, Omes C.2, Peltier A.2
1Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg, 2LuxDevelopment B.P.3503, Kigali, Rwanda, 3Centre Hospitalier Universitaire de Kigali, Kigali, Rwanda, 4Treatment and Research on AIDS Centre, Kigali, Rwanda

OBJECTIVES: Vertical transmission through breastfeeding remains a major problem in limited resources countries. The present study compares triple antiretroviral therapy (ART) given to breastfeeding (BF) mothers with formula feeding (FF) for prevention of post-natal mother-to-child transmission.

METHODS: All HIV-1 infected women followed at 4 antenatal care sites in Kigali were offered to participate in the study. All received NNRTI-based HAART starting after the second trimester of pregnancy.Women were given the choice between FF or BF with weaning at 6 months. The latter group continued ART until 1 month after the end of BF.

RESULTS: 572 women were enroled. 528 children have been born as of March 1, 2007 . 304 mothers (58%) opted for FF while 224 (42%) choose BF under ART. Diagnostic PCR is so far available for 419 babies at 6 weeks of age and for 236 at 7 months of age. Among these, 6 children are infected with HIV (1,4%). All 6 had a positive PCR already at birth and, among those tested so far, none has become infected through breastfeeding under ART. Psychomotor development was assessed at different timepoints and we found no difference between BF and FF children. No significant difference in morbidity was observed, with 1,23 disease episodes during the first 6 months in FF children compared to 1,21 episodes in BF children (p=0,81). The difference in mortality was not significant either: 9 children under AF died (2,9%), compared to 3 (1,3%) under BF (p=0,12).

CONCLUSIONS: Breastfeeding under triple antiretroviral therapy in children born to HIV-1 infected mothers is a safe way of avoiding HIV-1 infection in the baby while keeping the benefits of breastfeeding and avoiding the stigmatisation and risks of artificial feeding.

Acrobat ReaderDownload PDF of this abstract.

Power Point PresentationDownload Power Point Presentation.

2007-07-22
TUAX102
Prevention of Mother-to-Child Transmission

Copyright © 2007 - International AIDS Society (IAS). All information and content relating to the abstracts from the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.